Gainers
- Curis CRIS stock rose 202.08% to $4.35 during Tuesday's pre-market session. The market value of their outstanding shares is at $255.8 million.
- NeuroMetrix NURO stock moved upwards by 84.65% to $3.97. The market value of their outstanding shares is at $15.0 million.
- Lexicon Pharmaceuticals LXRX shares increased by 28.32% to $2.22. The market value of their outstanding shares is at $260.7 million.
- Cancer Genetics CGIX shares moved upwards by 28.01% to $3.29. The company's market cap stands at $13.4 million.
- Regulus Therapeutics RGLS stock increased by 12.34% to $0.91. The company's market cap stands at $35.6 million.
- electroCore ECOR stock rose 10.73% to $1.65. The company's market cap stands at $74.9 million.
Losers
- Obalon Therapeutics OBLN shares fell 16.09% to $1.93 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.9 million.
- Sundial Growers SNDL shares decreased by 10.12% to $0.47. The market value of their outstanding shares is at $350.4 million.
- Marinus Pharmaceuticals MRNS stock decreased by 9.61% to $14.11. The company's market cap stands at $431.6 million.
- Trillium Therapeutics TRIL shares decreased by 7.71% to $14.14. The market value of their outstanding shares is at $1.4 billion.
- Sutro Biopharma STRO stock declined by 7.08% to $20.35. The company's market cap stands at $785.5 million.
- Arcturus Therapeutics ARCT shares declined by 5.79% to $116.51. The company's market cap stands at $2.8 billion.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in